Fatal intratumoral hemorrhage in a patient with hepatocellular carcinoma following successful treatment with atezolizumab/bevacizumab: A case report

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 22

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Aug 6, 2024; 12(22): 5177-5183
Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.5177

Full Size Figure Download Figure

Figure 1 Clinical course of the patient. AFP: Alpha-fetoprotein; CT: Computed tomography; HCC: Hepatocellular carcinoma.

Citation: Park KH, Yoo JJ, Kim SG, Kim YS. Fatal intratumoral hemorrhage in a patient with hepatocellular carcinoma following successful treatment with atezolizumab/bevacizumab: A case report. World J Clin Cases 2024; 12(22): 5177-5183
URL: https://www.wjgnet.com/2307-8960/full/v12/i22/5177.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i22.5177

Park KH, Yoo JJ, Kim SG, Kim YS. Fatal intratumoral hemorrhage in a patient with hepatocellular carcinoma following successful treatment with atezolizumab/bevacizumab: A case report. World J Clin Cases 2024; 12(22): 5177-5183 [PMID: 39109046 DOI: 10.12998/wjcc.v12.i22.5177]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.